Reduced coenzyme Q10, as the active form of coenzyme Q10, is experiencing continuously growing demand in the pharmaceutical, health product, and cosmetic fields due to its excellent antioxidant properties and bioavailability. Microbial fermentation, with its high purity, high activity, and environmental friendliness, has become the mainstream technology for preparing reduced coenzyme Q10. Its core lies in optimizing strain selection, fermentation processes, and metabolic regulation to achieve efficient synthesis and stable production of the target product.
Strain selection is the foundation of microbial fermentation. Photosynthetic bacteria, due to their unique metabolic pathways and high coenzyme Q10 synthesis potential, have become a research hotspot. Among them, Rhodospirillum bacteria are widely used in fermentation production because they generally have high coenzyme Q10 content, rapid growth, and strong adaptability. Modifying photosynthetic bacteria through genetic engineering techniques, such as cloning key enzyme genes (e.g., the 2,3-dimethoxy-5-methyl-6-decanoylbenzenequinone synthase gene) into photosynthetic bacteria and enhancing their expression, can significantly improve the strain's coenzyme Q10 synthesis capacity. Furthermore, traditional mutagenesis breeding methods (such as UV mutagenesis and chemical mutagenesis) combined with rational screening can also effectively improve the yield and genetic stability of strains.
Optimizing the fermentation process is key to increasing the yield of reduced coenzyme Q10. During fermentation, parameters such as temperature, pH, and dissolved oxygen must be precisely controlled to provide the optimal growth environment for microorganisms. For example, appropriately reducing the oxygen respiration rate can enhance coenzyme Q10 production, as oxygen concentration has a significant impact on the metabolic regulation of coenzyme Q10 biosynthesis. Simultaneously, by using fed-batch fermentation, timely addition of precursor substances (such as L-phenylalanine) or carbon sources (such as soybean oil) during fermentation can further increase product yield. In addition, optimizing the culture medium formulation and adding specific nutrients and growth factors can also significantly improve the synthesis efficiency of coenzyme Q10.
Metabolic regulation is equally crucial in the fermentation production of reduced coenzyme Q10. In-depth research into the metabolic pathways and regulatory mechanisms of microorganisms can identify key nodes for improving coenzyme Q10 yield. For example, polyisoprene pyrophosphate synthase is a key enzyme in the synthesis of coenzyme Q10 side chains; enhancing its expression can promote coenzyme Q10 synthesis. Furthermore, the condensation reaction of p-hydroxybenzoic acid with polyisoprene catalyzed by p-hydroxybenzoic acid polyisoprene pyrophosphate transferase is the rate-limiting step in coenzyme Q10 synthesis; optimizing this reaction condition can also increase product yield.
During fermentation, the dynamic balance between cell growth and product synthesis needs to be monitored. Through mathematical modeling and optimization of model parameters, changes in cell biomass, product synthesis, and substrate consumption during coenzyme Q10 fermentation can be predicted, providing a theoretical basis for optimizing the fermentation process. Simultaneously, using biochemical engineering control methods, such as the combined use of neural networks and genetic algorithms, can further optimize the fermentation medium formulation and improve production efficiency.
Extraction and purification are the final steps in the preparation of reduced coenzyme Q10. Since coenzyme Q10 is an intracellular product obtained from microbial fermentation, cell wall disruption is necessary first. Common cell disruption methods include organic solvent stirring, grinding, and ultrasonic disruption. During extraction, saponification can be used to release coenzyme Q10 from cells, followed by organic solvent extraction and chromatographic separation to obtain a high-purity product. To maintain the stability of reduced coenzyme Q10, light and high-temperature environments should be avoided during extraction, and antioxidants (such as vitamin C) can be added for protection.
The application of physical stabilization methods such as co-crystallization can effectively reduce the oxidation risk of reduced coenzyme Q10 and improve its stability and bioavailability. Co-crystallization technology can prepare reduced coenzyme Q10 with specific crystal structures, exhibiting superior stability and bioavailability compared to traditional products. Furthermore, encapsulating reduced coenzyme Q10 with unsaturated fatty acids or other oils can also effectively maintain its stability in the reduced state and reduce oxidation risk.
